Quick Heal Technologies (QUICKHEAL) Q2 26/27 earnings summary

Executive summary

• Q2 FY27 revenue was ₹64.9 Cr, EBITDA ₹2.3 Cr and PAT ₹5.8 Cr, returning to positive EBITDA and PAT after Q1 losses.

• Management cited improved operating performance and is prioritizing execution discipline, go-to-market focus, innovation and profitable growth in H2 FY27.

Financial highlights

• Q2 revenue fell 22.3% YoY and rose 44.3% QoQ; EBITDA was ₹2.3 Cr, down 75.2% YoY and up 113.0% QoQ.

• Q2 PAT was ₹5.8 Cr, down 26.8% YoY and up 209.7% QoQ; diluted EPS was ₹1.00.

• H1 FY27 revenue was ₹109.9 Cr, EBITDA loss ₹15.3 Cr and PAT ₹0.5 Cr, versus H1 FY26 revenue ₹140.8 Cr, EBITDA loss ₹0.5 Cr and PAT ₹2.4 Cr.

• Q2 gross margin was 93.5%, versus 96.9% in Q2 FY26 and 98.2% in Q1 FY27; EBITDA margin was 3.5% and PAT margin 8.9%.

Outlook and guidance

• H2 FY27 priorities include sharpening go-to-market by product and customer segment, improving execution discipline, and accelerating innovation and market penetration.

• Strategic focus includes expanding cybersecurity, data protection and privacy offerings, global reach, and penetration of large and mid-sized enterprise customers.